Fasciola hepatica excretory-secretory products attenuate demyelination and reduce neuroinflammation in the Cuprizone –induced multiple sclerosis model

• Aliakbar Mariki,

  Roles Conceptualization, Investigation, Writing – original draft

  Affiliation Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran

  ⨯
• Kristi Anne Kohlmeier,

  Roles Validation, Writing – review & editing

  Affiliation Department of Drug Design and Pharmacology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Seyed Mohammad Mousavi,

  Roles Validation, Writing – review & editing

  Affiliation Research Center for Hydatid Disease in Iran, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

  ⨯
• Alireza Keyhani,

  Roles Methodology, Writing – review & editing

  Affiliation Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran

  ⨯
• Majid Fasihi Harandi,

  Roles Methodology, Writing – review & editing

  Affiliation Research Center for Hydatid Disease in Iran, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

  ⨯
• Mansoureh Sabzalizadeh,

  Roles Methodology

  Affiliations Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran, Cognitive Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran

  ⨯
• Mohammad Shabani

  Roles Conceptualization, Supervision, Validation, Writing – review & editing

  * E-mail: shabanimoh@yahoo.com, shabani@kmu.ac.ir

  Affiliation Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran

  https://orcid.org/0000-0002-2082-5849

  ⨯